Prevateur Ethical Stance of the Pharma Industry
Pharmaceutical industry has been challenged with more than its fair share of ethical dilemmas. Even though generally considered an industry vital to the health and lives of people, this industry has also faced challenges like no other industry because of the very fact that it deals with lives and health of the public. The pharmaceutical industry believes in developing drugs for the general and specific benefit of the population and they would do every in their power to accomplish this task with absolutely care. However there are things where they may not compromise which can lead to ethical problems. One such area is drug prices. We all know that prescription drugs though considered ethical drugs are very high in prices and the more specific the target, the higher the price. Those who do not have insurance can find themselves in a very bad situation if they have to purchase these drugs on regular basis. Even though pharmaceutical industry can lower the prices, they do not wish to do this on the pretext of the investment and the high cost of research and development of the product.
Pharmaceutical industry therefore believes that as long as it meets the standards prescribed by FDA and other regulatory agencies they are being highly ethical in the production of drugs and hence they do not need to compromise on the price. It must be noted that many prescription drugs have their generic version...
While pharmaceutical companies make millions through these drugs, they hardly ever realize the struggle that an insured person goes through in purchasing these drugs. Even those with insurance are often left high and dry when some drugs are not covered by their insurance.
Pharmaceutical industry on the other hand doesn't consider this an ethical dilemma that needs to be addressed. Instead for this industry and its major players, ethics is all about the way their products are developed and their final results. Companies like Merck would invest heavily in research and development to come up with breakthrough drugs. The cost of producing these drugs is often overestimated and overinflated in order to justify their final price. But from the view point of the industry, it is more important to develop products that truly work and that have years of research behind them instead of worrying about the price that consumer will have to pay for them. That is the reason they call prescription drugs "ethical drugs."
Scenario planning:
Decision identification:
The pharmaceutical industry is faced with various challenges for the future which can affect the progress of the sector. The one important decision it needs to make is regarding high cost of…
This relationship has an effect on the payment rates that CMS sets. Higher cost pharmaceutical therapies are systematically reimbursed below acquisition cost (i.e., the payment system is biased against full reimbursement for higher cost therapies). Reimbursement compared to acquisition cost for the top IO pharmaceuticals by total expenditures indicates that 9 of the 10 are significantly under reimbursed." Clinical Trials Report: Congress established Medicare beneficiaries numbering 40 million with a prescription
38 per share on the company's common stock for the first quarter of 2005. The dividend is payable January 3, 2005 to stockholders of records at the close of business on December 3, 2004. Growth in the ZETIA and VYTORIN franchises are expected to continue. T There are currently several candidates in Phase III that Merck plans to file in 2005 as well as Type 2 diabetes treatment and three vaccines.
There are two constant irritations in U.S. pharma companies' relationships internationally: Some developing nations, such as India, Brazil and South Africa, are chipping away at the patent situation, trying to shorten the time until the drugs can be brought out in generic form. The U.S. has supported high prices as the cost for innovation. Since other countries are not playing along, this means that their citizens are benefiting from the innovation paid
For example, before its paten ran out, "the price of Schering-Plough's top-selling allergy pill, Claritin, was raised thirteen times over fives years, for a cumulative increase of more than 50%, over four times the rate of general inflation." In 2002, the average price of the fifty drugs most used by senior citizens was approximately $1,500 for a year's supply, and although this refers to what the companies call the
Pharmaceutical Ethics Issues Generally, business ethics is a concept that has not been upheld or exemplified to any high standard by the modern pharmaceutical industry. It is an industry frequently plagued by unethical marketing decisions and practices, the pursuit of business strategies and policies that violate public trust in spirit if not necessarily in the written word, and that has embraced research practices that are sometimes highly questionable. In the modern
Since its inception, the Food and Drug act developed into the Food and Drug Administration, which is responsible for oversight and administration of the rules. Once an application to test a new drug compound has been approved, it must pass a series of tests. Only about 23% of all drug compounds that enter into Phase I ever make it through this phase and into the second phase (Scherer, 2000). This